Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Analytical Method Development: SOP for System Performance Qualification of UV-Visible Spectrophotometer – V 2.0

Posted on By

Analytical Method Development: SOP for System Performance Qualification of UV-Visible Spectrophotometer – V 2.0

Standard Operating Procedure for System Performance Qualification of UV-Visible Spectrophotometer in Analytical Method Development


Department Analytical Method Development
SOP No. SOP/AMD/337/2025
Supersedes SOP/AMD/337/2022
Page No. Page 1 of 12
Issue Date 01/06/2025
Effective Date 03/06/2025
Review Date 01/06/2026

1. Purpose

The purpose of this SOP is to define the steps for conducting system performance qualification (PQ) of UV-Visible spectrophotometers used in analytical method

development laboratories. The PQ ensures the instrument meets accuracy, precision, wavelength calibration, and photometric linearity standards before being used for routine analysis or validation work.

2. Scope

This SOP applies to all UV-Visible spectrophotometers located in the Analytical Method Development (AMD) department of the pharmaceutical facility, whether used for method development, transfer, or validation projects.

3. Responsibilities

  • Analytical Scientist: Conducts the PQ as per defined procedures and records the results.
  • QA Personnel: Reviews the PQ data and ensures compliance with acceptance criteria.
  • Instrument Coordinator: Maintains qualification schedule and tracks PQ status.
See also  Analytical Method Development: SOP for Content Uniformity in Capsules - V 2.0

4. Accountability

The Head of Analytical Method Development is accountable for ensuring that system PQ is performed timely and accurately, and that instruments not meeting qualification requirements are not used for analytical purposes.

5. Procedure

5.1 Preparation Before Qualification

  1. Ensure the instrument is installed and calibrated as per manufacturer guidelines.
  2. Verify the availability of certified reference materials (CRMs), including potassium dichromate, holmium oxide filters, and neutral density filters.
  3. Clean all optical paths, sample holders, and cuvettes using lint-free tissue and appropriate solvent.

5.2 Wavelength Accuracy Test

  1. Use a holmium oxide filter or certified solution to verify characteristic absorbance peaks.
  2. Scan from 200 nm to 600 nm.
  3. Confirm absorbance peaks at certified wavelengths such as 241 nm, 279 nm, 287 nm, 361 nm, and 536 nm within ±1 nm.

5.3 Photometric Accuracy

  1. Prepare a 60 mg/L solution of potassium dichromate in 0.005 M sulfuric acid.
  2. Measure absorbance at 235 nm, 257 nm, 313 nm, and 350 nm using a 1 cm cell and record values.
  3. Compare observed absorbance with certified values and confirm deviation is within ±0.01 A.
See also  Analytical Method Development: Peak Purity Evaluation using PDA - V 2.0

5.4 Stray Light Test

  1. Use a 1.2% potassium chloride solution for stray light detection.
  2. Set wavelength at 200 nm. The absorbance should be greater than 2.0 A.

5.5 Resolution Test

  1. Scan a toluene in hexane solution (0.02% v/v) from 260 nm to 275 nm.
  2. Calculate the absorbance ratio of the maxima at 269 nm and minima at 266 nm.
  3. The absorbance ratio should be ≥1.5.

5.6 Linearity and Precision

  1. Prepare five different concentrations of potassium permanganate or neutral density filters.
  2. Record absorbance at a fixed wavelength (e.g., 530 nm).
  3. Plot concentration vs. absorbance and determine R². It should be ≥ 0.999 for linearity.
  4. Repeatability (RSD%) of three consecutive readings at each concentration should be ≤1.0%.

5.7 Documentation

  1. Fill out the System PQ Summary Log (Annexure-1).
  2. Attach scan printouts and calibration certificate copies to the logbook.
  3. Submit for QA review and approval before releasing the instrument for use.

6. Abbreviations

  • PQ: Performance Qualification
  • UV-Vis: Ultraviolet-Visible
  • CRM: Certified Reference Material
  • RSD: Relative Standard Deviation
  • QA: Quality Assurance

7. Documents

  1. Annexure-1: System PQ Summary Log Template
  2. Annexure-2: Certified Wavelength Peaks Reference Sheet
  3. Annexure-3: Photometric Linearity Calibration Curve
See also  Analytical Method Development: SOP for Establishing Stability-Indicating Nature of Method - V 2.0

8. References

  • ICH Q2(R1): Validation of Analytical Procedures
  • Pharmacopoeia Reference: USP <857> Spectrophotometry and Light Scattering
  • Instrument Manufacturer User Manuals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Shweta Mehra Rahul Kaul Dr. Priya Nambiar
Designation Analyst QA Officer Head – AMD
Department Analytical Method Development Quality Assurance Analytical Method Development

11. Annexures

Annexure-1: System PQ Summary Log Template

Date Test Performed Acceptance Criteria Results Status
01/06/2025 Wavelength Accuracy ±1 nm Pass Pass
01/06/2025 Photometric Accuracy ±0.01 A Pass Pass

Annexure-2: Certified Wavelength Peaks Reference Sheet

Includes certified absorbance values and tolerance limits for holmium oxide peaks used in wavelength calibration.

Annexure-3: Photometric Linearity Calibration Curve

Graph of absorbance vs. concentration with R² value and slope, signed and dated by the analyst and reviewer.

Revision History:

Revision Date Revision No. Details Reason Approved By
01/06/2025 2.0 Inclusion of Annexure formats and linearity validation criteria Periodic SOP revision Dr. Priya Nambiar
10/07/2022 1.0 Initial version New SOP implementation QA Head
Analytical Method Development V 2.0 Tags:Analytical Method Development SOP, SOP for analytical calculations, SOP for analytical documentation, SOP for analytical instrument calibration, SOP for analytical instrument qualification, SOP for analytical method change control, SOP for analytical method deviation handling, SOP for analytical method documentation practices, SOP for analytical method lifecycle management, SOP for analytical method optimization, SOP for analytical method risk assessment, SOP for analytical method training and competency, SOP for analytical method transfer protocol, SOP for analytical method validation, SOP for forced degradation studies, SOP for HPLC method development, SOP for limit of detection (LOD) determination, SOP for limit of quantitation (LOQ) determination, SOP for method accuracy testing, SOP for method linearity assessment, SOP for method precision evaluation, SOP for method reproducibility, SOP for method robustness testing, SOP for method transfer, SOP for method verification, SOP for qualification of working standards, SOP for reference standard handling, SOP for specificity testing in analytical methods, SOP for stability indicating methods, SOP for system suitability testing

Post navigation

Previous Post: Analytical Method Development: SOP for System Suitability Checks for Chromatographic Methods – V 2.0
Next Post: Elixir Department: SOP for Stability Indicating Testing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version